This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
In this issue of the Archives there appears an unusually fine Progress Report on Respiratory Infections and Antimicrobial Therapy. Prepared by Professor Saunders of Ohio State University, this is an extremely useful and practical summary of a rapidly changing and often confusing field due to the constant introduction of new agents, each accompanied by brightly colored advertising literature. Saunders agrees with the conclusions of a medical Progress Report in the New England Journal of Medicine for Nov. 10, 1960, that, although replaced in great part by antibiotics, sulfonamides, because of relative inexpensiveness, still occupy a small, but important place in the therapy of infectious diseases. Sulfadiazine, long the standard, has been largely replaced by sulfisoxazole, marketed as Gantrisin, because of the reduced toxicity of the latter.
Of the antibiotics, penicillin is still the "work-horse" with aqueous crystalline penicillin G, given intramuscularly or intravenously for rapid high serum concentrations. Procaine penicillin
Antimicrobial Therapy. Arch Otolaryngol. 1961;74(1):1. doi:10.1001/archotol.1961.00740030004001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: